JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M414132200 on May 27, 2005

J. Biol. Chem., Vol. 280, Issue 29, 27329-27338, July 22, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/29/27329    most recent
M414132200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pu, Y.
Right arrow Articles by Marquez, V. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pu, Y.
Right arrow Articles by Marquez, V. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Novel Diacylglycerol-lactone Shows Marked Selectivity in Vitro among C1 Domains of Protein Kinase C (PKC) Isoforms {alpha} and {delta} as Well as Selectivity for RasGRP Compared with PKC{alpha}*

Yongmei Pu{ddagger}§, Nicholas A. Perry{ddagger}§, Dazhi Yang{ddagger}, Nancy E. Lewin{ddagger}, Noemi Kedei{ddagger}, Derek C. Braun{ddagger}, Sung Hee Choi{ddagger}, Peter M. Blumberg{ddagger}, Susan H. Garfield||, James C. Stone**, Dehui Duan{ddagger}{ddagger}, and Victor E. Marquez{ddagger}{ddagger}

From the {ddagger} Laboratory of Cellular Carcinogenesis and Tumor Promotion, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892, || Laboratory of Experimental Carcinogenesis, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892, the **Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada, and {ddagger}{ddagger} Laboratory of Medicinal Chemistry, Center for Cancer Research, NCI-Frederick, National Institutes of Health, Frederick, Maryland 21702

Although multiple natural products are potent ligands for the diacylglycerol binding C1 domain of protein kinase C (PKC), RasGRP, and related targets, the high conservation of C1 domains has impeded the development of selective ligands. We characterized here a diacylglycerol-lactone, 130C037, emerging from a combinatorial chemical synthetic strategy, which showed substantial selectivity. 130C037 gave shallow binding curves for PKC isoforms {alpha}, {beta}, {gamma}, {delta}, and {epsilon}, with apparent Ki values ranging from 340 nM for PKC{alpha} to 29 nM for PKC{epsilon}. When binding to isolated C1 domains of PKC{alpha} and -{delta}, 130C037 showed good affinity (Ki = 1.78 nM) only for {delta}C1b, whereas phorbol 12,13-dibutyrate showed affinities within 10-fold for all. In LNCaP cells, 130C037 likewise selectively induced membrane translocation of {delta}C1b. 130C037 bound intact RasGRP1 and RasGRP3 with Ki values of 3.5 and 3.8 nM, respectively, reflecting 8- and 90-fold selectivity relative to PKC{epsilon} and PKC{alpha}. By Western blot of Chinese hamster ovary cells, 130C037 selectively induced loss from the cytosol of RasGRP3 (ED50 = 286 nM), partial reduction of PKC{epsilon} (ED50 > 10 µM), and no effect on PKC{alpha}. As determined by confocal microscopy in LNCaP cells, 130C037 caused rapid translocation of RasGRP3, limited slow translocation of PKC{epsilon}, and no translocation of PKC{alpha}. Finally, 130C037 induced Erk phosphorylation in HEK-293 cells ectopically expressing RasGRP3 but not in control cells, whereas phorbol ester induced phosphorylation in both. The properties of 130C037 provide strong proof of principle for the feasibility of developing ligands with selectivity among C1 domain-containing therapeutic targets.


Received for publication, December 16, 2004 , and in revised form, May 2, 2005.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this work.

To whom correspondence should be addressed: NCI, National Institutes of Health, Bldg. 37, Rm. 4048, 37 Convent Dr. MSC 4255, Bethesda, MD 20892-4255. Tel.: 301-496-3189; Fax: 301-496-8709; E-mail: blumberp{at}dc37a.nci.nih.gov.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. H. Choi, G. Czifra, N. Kedei, N. E. Lewin, J. Lazar, Y. Pu, V. E. Marquez, and P. M. Blumberg
Characterization of the Interaction of Phorbol Esters with the C1 Domain of MRCK (Myotonic Dystrophy Kinase-related Cdc42 Binding Kinase) {alpha}/{beta}
J. Biol. Chem., April 18, 2008; 283(16): 10543 - 10549.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Han, S. M. Knoepp, M. A. Hallman, and K. E. Meier
RasGRP1 Confers the Phorbol Ester-Sensitive Phenotype to EL4 Lymphoma Cells
Mol. Pharmacol., January 1, 2007; 71(1): 314 - 322.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Okamura, C. E. Oki-Idouchi, and P. S. Lorenzo
The Exchange Factor and Diacylglycerol Receptor RasGRP3 Interacts with Dynein Light Chain 1 through Its C-terminal Domain
J. Biol. Chem., November 24, 2006; 281(47): 36132 - 36139.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Pu, M. L. Peach, S. H. Garfield, S. Wincovitch, V. E. Marquez, and P. M. Blumberg
Effects on Ligand Interaction and Membrane Translocation of the Positively Charged Arginine Residues Situated along the C1 Domain Binding Cleft in the Atypical Protein Kinase C Isoforms
J. Biol. Chem., November 3, 2006; 281(44): 33773 - 33788.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
J. Das, X. Zhou, and K. W. Miller
Identification of an alcohol binding site in the first cysteine-rich domain of protein kinase C {delta}.
Protein Sci., September 1, 2006; 15(9): 2107 - 2119.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. H. Choi, T. Hyman, and P. M. Blumberg
Differential Effect of Bryostatin 1 and Phorbol 12-Myristate 13-Acetate on HOP-92 Cell Proliferation Is Mediated by Down-regulation of Protein Kinase C{delta}.
Cancer Res., July 15, 2006; 66(14): 7261 - 7269.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.